The American Association of Clinical Oncology conference is wrapping up in Chicago. The three day conference brings together thousands of oncology professionals and …
MLV analyst Arlinda Lee was out pounding the table on Agenus Inc (NASDAQ:AGEN) Wednesday, reiterating a Buy rating and price target of $9.00, which implies an upside of …
Agenus, Inc (NASDAQ: AGEN) announced a global alliance with Incyte Corp. (NASDAQ: INCY) to develop cancer therapies.
In a research report released Friday, MLV analyst George Zavoico reiterated a Buy rating on Agenus (NASDAQ:AGEN) and raised his price target to $9.00 …
In a research report issued today, H.C.
